The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Tahir Misbah since 2020.
This trader's CIK number is 1787359.
At the time of last reporting, Tahir Misbah was the CHIEF FINANCIAL OFFICER of Igm Biosciences, Inc.. (stock ticker symbol IGMS).
Also see all insider trading activities at Igm Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | IGMS | 0 | $0 | 17,592 | $21,965 | 0 | $0 |
| 2024 | IGMS | 0 | $0 | 10,205 | $96,296 | 0 | $0 |
| 2023 | IGMS | 0 | $0 | 4,364 | $55,811 | 0 | $0 |
| 2022 | IGMS | 0 | $0 | 6,961 | $138,565 | 0 | $0 |
| 2021 | IGMS | 0 | $0 | 0 | $0 | 2,750 | $3,822 |
| 2020 | IGMS | 0 | $0 | 0 | $0 | 2,750 | $3,822 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-23 | IGMS | Sale | 8,741 | 1.27 | 11,127 |
| 2025-06-16 | IGMS | Sale | 1,522 | 1.20 | 1,824 |
| 2025-03-14 | IGMS | Sale | 7,329 | 1.23 | 9,014 |
| 2024-12-16 | IGMS | Sale | 1,708 | 7.48 | 12,775 |
| 2024-09-13 | IGMS | Sale | 1,487 | 11.54 | 17,158 |
| 2024-06-14 | IGMS | Sale | 1,570 | 7.58 | 11,892 |
| 2024-03-13 | IGMS | Sale | 2,897 | 9.88 | 28,607 |
| 2024-03-14 | IGMS | Sale | 2,543 | 10.17 | 25,864 |
| 2023-11-27 | IGMS | Sale | 1,337 | 5.06 | 6,763 |
| 2023-05-23 | IGMS | Sale | 1,259 | 12.65 | 15,930 |
| 2023-03-14 | IGMS | Sale | 1,768 | 18.73 | 33,118 |
| 2022-12-16 | IGMS | Sale | 2,283 | 19.07 | 43,529 |
| 2022-12-19 | IGMS | Sale | 3,801 | 20.00 | 76,020 |
| 2022-11-23 | IGMS | Sale | 877 | 21.68 | 19,016 |
| 2021-03-05 | IGMS | Option Ex | 2,750 | 1.39 | 3,822 |
| 2020-12-21 | IGMS | Option Ex | 2,750 | 1.39 | 3,822 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tahir Misbah (CHIEF FINANCIAL OFFICER of Igm Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.